XML 34 R13.htm IDEA: XBRL DOCUMENT v3.20.1
Derivative Instruments
3 Months Ended
Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments Derivative Instruments

The Company periodically holds interest rate derivative instruments to mitigate exposure to changes in interest rates, predominantly one-month LIBOR, with $645.0 million and $404.3 million of variable rate borrowings at March 31, 2020 and December 31, 2019, respectively. As a matter of policy, management does not use derivatives for speculative purposes.  As of March 31, 2020, the Company has two interest rate swap agreements. One interest rate swap agreement was entered into during 2016 which has a notional outstanding amount of $100.0 million, with a remaining term of 13 months as of March 31, 2020. During 2019, the Company entered into one additional fixed-rate interest swap agreement which has a notional outstanding amount of $100.0 million, with a remaining term of 51 months as of March 31, 2020. The derivative instruments were designated as cash flow hedges and recorded at fair value.

The Company evaluated the effectiveness of the swaps to hedge the interest rate risk associated with its variable rate debt and concluded at the swap inception dates that the swaps were highly effective in hedging that risk. The Company evaluates the effectiveness of the hedging relationships on an ongoing basis.

The Company estimates the fair value of derivative instruments using a discounted cash flow technique and has used creditworthiness inputs that corroborate observable market data when evaluating the Company’s and counterparty’s risk of non-performance. Valuation of the derivative instruments requires certain assumptions for underlying variables and the use of different assumptions would result in a different valuation. Management believes it has applied assumptions consistently during the period. The Company applies hedge accounting and accounts for the change in fair value of its cash flow hedges through other comprehensive income for all derivative instruments.

The net fair value of the interest rate swaps was a $5.0 million and $1.7 million net liability as of March 31, 2020 and December 31, 2019, respectively. The Company recorded an adjustment to interest expense of $36.0 thousand and $(0.2) million during the three months ended March 31, 2020 and 2019, respectively, from derivative instruments.

Effect of Derivative Instruments on Earnings in the Statements of Income and on Comprehensive Income 

The following tables provide additional information about the financial statement effects related to the cash flow hedges for the three months ended March 31, 2020 and 2019:
Derivatives in Cash Flow Hedging Relationships
 
Amount of Loss Recognized
in OCI on Derivatives
(Effective Portion)
 
Location of Loss (Gain)
Reclassified from
Accumulated OCI into
Income
(Effective Portion)
 
Amount of Loss (Gain) Reclassified
from Accumulated OCI into Income
(Effective Portion)
 
Three Months Ended March 31,
 
 
Three Months Ended March 31,
 
2020
 
2019
 
 
2020
 
2019
 
 
(in thousands)
 
 
 
(in thousands)
Interest rate contracts
 
$
3,318

 
$
613

 
Interest expense
 
$
36

 
$
(203
)
Total
 
$
3,318

 
$
613

 
Total
 
$
36

 
$
(203
)

The effective portion of the change in fair value on a derivative instrument designated as a cash flow hedge is reported as a component of other comprehensive income and is reclassified into earnings in the period during which the transaction being hedged affects earnings or it is probable that the forecasted transaction will not occur. The ineffective portion of the hedges, if any, is recorded in earnings in the current period. There was no ineffectiveness in the hedge for the period ended March 31, 2020.

Counterparty Credit Risk

The Company evaluates the creditworthiness of the counterparties under its hedging agreements. The counterparties for the interest rate swaps are large financial institutions that possessed investment grade credit ratings. Based on these ratings, the Company believes that the counterparties were credit-worthy and that their continuing performance under the hedging agreements was probable and did not require the counterparties to provide collateral or other security to the Company.